Ketan Paranjape - 21 Nov 2025 Form 4 Insider Report for Syra Health Corp (SYRA)

Role
Director
Signature
/s/ Ketan Paranjape
Issuer symbol
SYRA
Transactions as of
21 Nov 2025
Net transactions value
$0
Form type
4
Filing time
25 Nov 2025, 19:12:56 UTC
Previous filing
08 Jan 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Paranjape Ketan Director C/O SYRA HEALTH CORP., 1119 KEYSTONE WAY N., #201, CARMEL /s/ Ketan Paranjape 25 Nov 2025 0001962333

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SYRA Stock Options Award $0 +43,348 +126% $0.000000 77,821 21 Nov 2025 Class A Common Stock 43,348 $0.0700 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were issued pursuant to the Issuer's 2022 Omnibus Equity Incentive Plan. 1/3 of the options vest on December 31, 2025 and the remainder vest in equal amounts on each of December 31, 2026 and 2027.